Life Technologies Gets FDA Clearance for CE Sequencing Systems, HLA Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said today that it has received US Food and Drug Administration 510(k) clearance for capillary electrophoresis sequencing systems and an HLA typing assay.

The company's 3500 Dx Genetic Analyzers and its SeCore HLA typing kits are the first 510(k)-cleared, sequencing-based systems for HLA typing in the US, the firm noted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.